A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of Guselkumab in Subjects with Active Lupus Nephritis
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Scope
National
Locations
Barbara Davis Center
University of Colorado Hospital
Study ID
Protocol Number: 20-1490
More information available at ClinicalTrials.gov: NCT04376827
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers